Mitsubishi UFJ Trust & Banking
ARQT icon

Mitsubishi UFJ Trust & Banking’s Arcutis Biotherapeutics ARQT Stock Holding History

Mitsubishi UFJ Trust & Banking’s Portfolio ARQT Stock Details ARQT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$222K Buy
+8,485
New +$198K ﹤0.01% 1304
2026
Q1 		– Sell
-14,208
Closed -$413K – 1104
2025
Q4 		$413K Buy
+14,208
New +$364K ﹤0.01% 989

Other funds holding ARQT

SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Mitsubishi UFJ Trust & Banking's ARQT Position: Q2 2026 in Review

Mitsubishi UFJ Trust & Banking opened a new position in Arcutis Biotherapeutics (ARQT) in Q2 2026: 8,485 shares worth $222K. The stake represents ﹤0.01% of the portfolio and ranks #1304 among its holdings. This is a return to the name: Mitsubishi UFJ Trust & Banking previously reported a position in ARQT as recently as Q4 2025.

Mitsubishi UFJ Trust & Banking first reported a position in ARQT in Q4 2025 and has held it in 2 quarters since. The position peaked at $413K in Q4 2025. 273 funds tracked by Wall St. Rank hold ARQT as of Q2 2026.

  • Mitsubishi UFJ Trust & Banking held 8,485 shares of Arcutis Biotherapeutics worth $222K as of Q2 2026.
  • Arcutis Biotherapeutics was a new Mitsubishi UFJ Trust & Banking position in Q2 2026.
  • Arcutis Biotherapeutics made up ﹤0.01% of Mitsubishi UFJ Trust & Banking's portfolio in Q2 2026, its #1304 holding.
  • Mitsubishi UFJ Trust & Banking first reported a position in Arcutis Biotherapeutics in Q4 2025 and has held it in 2 quarters since.
  • Mitsubishi UFJ Trust & Banking's Arcutis Biotherapeutics position peaked at $413K in Q4 2025.
  • 273 funds tracked by Wall St. Rank held Arcutis Biotherapeutics as of Q2 2026.

Based on Mitsubishi UFJ Trust & Banking's 13F filing for Q2 2026, filed 6 Aug 2026.